chevron_leftBack
As of 14 June 2026, Tissue Repair Ltd. has a market cap of $6.59M USD, ranking #43341 globally and #1474 in Australia.
It ranks #3836 in the Healthcare sector, and #1237 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$6.59MUSD
9.37M AUD
Enterprise Value
$759.15KUSD
1.08M AUD
Revenue (TTM)
$2.38MUSD
3.38M AUD
EBITDA (TTM)
-$2.62MUSD
-3.71M AUD
Net Income (TTM)
-$2.71MUSD
-3.85M AUD
EBITDA Margin
-110%
Profit Margin
-114%
PS Ratio
2.8
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Tony Charara
open_in_new
Founded
2012
Website
tissuerepair.com.au
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -16% | -8.8% | 3.3% | -49% | -49% | -29% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
TRP
Tissue Repair Ltd
ISIN: AU0000180887
Shares Out.:
Shares Outstanding:
60.465M1
Shares Float:
55.569M2
|
0.1300 AUD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Tissue Repair Ltd.
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical drug in Phase III clinical trial for the treatment of chronic wounds and venous leg ulcers; and TR Pro+, a post-procedure gel for the aftercare of acute wounds, and aesthetic and medical procedures. Tissue Repair Ltd was incorporated in 2012 and is based in Chatswood, Australia.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
ASX: SIG
|
$22.48B
341K%
31.98B AUD
|
52.3
|
|
ASX: PYC
|
$912.31M
14K%
1.3B AUD
|
-
|
|
ASX: RAC
|
$341.04M
5K%
485.18M AUD
|
-
|
|
ASX: CUV
|
$330.36M
5K%
469.99M AUD
|
14.5
|
|
ASX: SPL
|
$213.14M
3K%
303.23M AUD
|
-
|
|
ASX: MYX
|
$163.9M
2K%
233.18M AUD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
12M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
8M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
5M%
|
97.4
|
|
SIX: RO
|
$321.52B
5M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
4M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
4M%
218.9B CHF
|
20.5
|
chevron_leftBack